Antiretroviral therapy hiv 1. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy8

CD4-Positive T-Lymphocytes Plasma CD8-Positive T-Lymphocytes Leukocytes, Mononuclear T-Lymphocyte Subsets T-Lymphocytes Semen Cerebrospinal Fluid

Organisms7

HIV-1 HIV HIV-2 Proviruses Simian immunodeficiency virus Macaca mulatta GB virus C

Diseases35

HIV Infections Acquired Immunodeficiency Syndrome HIV Seropositivity AIDS-Related Opportunistic Infections HIV-Associated Lipodystrophy Syndrome Immune Reconstitution Inflammatory Syndrome Viremia AIDS Dementia Complex Pregnancy Complications, Infectious Coinfection Lymphoma, AIDS-Related Cytomegalovirus Retinitis HIV Wasting Syndrome Tuberculosis Lipodystrophy Disease Progression Substance Abuse, Intravenous AIDS-Associated Nephropathy Sarcoma, Kaposi Hepatitis C Acidosis, Lactic Meningitis, Cryptococcal Pneumonia, Pneumocystis Simian Acquired Immunodeficiency Syndrome Toxoplasmosis, Cerebral Tuberculosis, Pulmonary Leukoencephalopathy, Progressive Multifocal Substance-Related Disorders Dyslipidemias Drug-Induced Liver Injury Anus Neoplasms Mycobacterium avium-intracellulare Infection Candidiasis, Oral Hepatitis B Mouth Diseases

Chemicals and Drugs50

Anti-HIV Agents Anti-Retroviral Agents HIV Protease Inhibitors Reverse Transcriptase Inhibitors RNA, Viral Zidovudine Stavudine Nevirapine Benzoxazines Ritonavir Organophosphonates Lamivudine Lopinavir Indinavir HIV Reverse Transcriptase Adenine Pyrimidinones Didanosine Nelfinavir HIV Protease Dideoxynucleosides Oxazines Antitubercular Agents Saquinavir Antiviral Agents pol Gene Products, Human Immunodeficiency Virus DNA, Viral HIV Antigens Pyrrolidinones HIV Core Protein p24 HIV Integrase Inhibitors HIV Fusion Inhibitors Protease Inhibitors Trimethoprim-Sulfamethoxazole Combination Receptors, CCR5 Biological Markers Cyclohexanes Receptors, HIV HIV Envelope Protein gp120 Drugs, Generic Drug Combinations HIV Envelope Protein gp41 HIV Antibodies AIDS Vaccines Methadone Integrase Inhibitors gag Gene Products, Human Immunodeficiency Virus Antigens, CD38 Gene Products, pol Drugs, Investigational

Analytical, Diagnostic and Therapeutic Techniques and Equipment54

Antiretroviral Therapy, Highly Active CD4 Lymphocyte Count Viral Load Cohort Studies Drug Therapy, Combination Treatment Outcome Treatment Failure Lost to Follow-Up Drug Monitoring Directly Observed Therapy Prospective Studies Drug Administration Schedule Risk Factors Cross-Sectional Studies Retrospective Studies Prevalence Follow-Up Studies Incidence CD4-CD8 Ratio Longitudinal Studies HIV Seroprevalence Withholding Treatment Multivariate Analysis Lymphocyte Count AIDS Serodiagnosis Proportional Hazards Models Logistic Models Chemoprevention Survival Analysis Pilot Projects Kaplan-Meier Estimate Life Expectancy Lymphocyte Activation Case-Control Studies Epidemiologic Methods Regression Analysis Questionnaires Clinical Trials as Topic Sequence Analysis, DNA Statistics, Nonparametric Interviews as Topic Models, Statistical Drug Substitution Mass Screening Flow Cytometry Confidence Intervals Condoms Odds Ratio Polymerase Chain Reaction Sensitivity and Specificity Models, Theoretical Population Surveillance Randomized Controlled Trials as Topic Program Evaluation

Psychiatry and Psychology17

Medication Adherence Patient Compliance AIDS Dementia Complex Substance Abuse, Intravenous Treatment Refusal Homosexuality, Male Sexual Behavior Risk-Taking Counseling Social Stigma Substance-Related Disorders Health Knowledge, Attitudes, Practice Heterosexuality Stereotyping HIV Serosorting Unsafe Sex Safe Sex

Phenomena and Processes24

CD4 Lymphocyte Count Viral Load Drug Resistance, Viral Drug Resistance, Multiple, Viral HIV Seronegativity Time Factors Virus Replication Pregnancy CD4-CD8 Ratio Homosexuality, Male Lymphocyte Count Virus Latency Genotype Drug Interactions Viral Tropism Mutation Genes, pol Virus Shedding Lymphocyte Activation Heterosexuality Phylogeny Mutation, Missense Odds Ratio Sensitivity and Specificity

Anthropology, Education, Sociology and Social Phenomena7

Developing Countries Treatment Refusal Socioeconomic Factors Prisons Developed Countries Social Support Demography

Information Science7

Prevalence Incidence Life Expectancy Questionnaires Phylogeny Interviews as Topic Molecular Sequence Data

Named Groups6

HIV Long-Term Survivors Infant, Newborn Sexual Partners Drug Users Prisoners Patient Dropouts

Health Care64

Medication Adherence Cohort Studies Infectious Disease Transmission, Vertical Patient Compliance Treatment Outcome Treatment Failure Prospective Studies Risk Factors Cross-Sectional Studies Retrospective Studies Prevalence Follow-Up Studies Incidence Longitudinal Studies HIV Seroprevalence Treatment Refusal Withholding Treatment Multivariate Analysis Health Services Accessibility Proportional Hazards Models Logistic Models Ambulatory Care Facilities Rural Population Health Resources Epidemics Survival Analysis Socioeconomic Factors Pilot Projects World Health Organization Counseling Kaplan-Meier Estimate Cost-Benefit Analysis Life Expectancy Health Knowledge, Attitudes, Practice Case-Control Studies Drug Costs Epidemiologic Methods Regression Analysis Questionnaires Age Factors Delivery of Health Care Clinical Trials as Topic Patient Acceptance of Health Care Sex Factors Statistics, Nonparametric Interviews as Topic Models, Statistical Drug Substitution Eligibility Determination Urban Population World Health Mass Screening Disease Transmission, Infectious National Health Programs Comorbidity Confidence Intervals Health Facilities Odds Ratio Health Care Costs Demography Sensitivity and Specificity Population Surveillance Randomized Controlled Trials as Topic Program Evaluation

Geographicals34

South Africa Uganda Malawi Botswana Africa South of the Sahara Zambia Cote d'Ivoire Zimbabwe Africa, Southern Cameroon Haiti Kenya Thailand Lesotho Rwanda Cambodia United States British Columbia Tanzania India Brazil Mozambique Africa San Francisco Ethiopia Nigeria Asia Togo Africa, Western Namibia Africa, Eastern Swaziland China France

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Anthropology, Education, Sociology and Social Phenomena Information Science Named Groups Health Care Geographicals

Antiretroviral Therapy, Highly Active HIV Infections Anti-HIV Agents Anti-Retroviral Agents CD4 Lymphocyte Count Viral Load HIV-1 Acquired Immunodeficiency Syndrome HIV Seropositivity HIV Protease Inhibitors Drug Resistance, Viral Reverse Transcriptase Inhibitors HIV AIDS-Related Opportunistic Infections South Africa RNA, Viral Medication Adherence Zidovudine Stavudine Nevirapine Benzoxazines Cohort Studies Infectious Disease Transmission, Vertical Drug Therapy, Combination HIV-Associated Lipodystrophy Syndrome Uganda Ritonavir Patient Compliance Immune Reconstitution Inflammatory Syndrome Viremia CD4-Positive T-Lymphocytes Organophosphonates Lamivudine Lopinavir Treatment Outcome Treatment Failure AIDS Dementia Complex Indinavir Pregnancy Complications, Infectious Lost to Follow-Up Drug Resistance, Multiple, Viral Malawi Coinfection HIV Reverse Transcriptase Adenine Botswana Pyrimidinones Didanosine HIV Seronegativity Lymphoma, AIDS-Related Nelfinavir Drug Monitoring Directly Observed Therapy Africa South of the Sahara Zambia Prospective Studies Drug Administration Schedule Risk Factors HIV Protease Cote d'Ivoire Dideoxynucleosides Time Factors Cross-Sectional Studies Retrospective Studies Cytomegalovirus Retinitis Prevalence Zimbabwe HIV Wasting Syndrome Tuberculosis Africa, Southern Lipodystrophy Virus Replication HIV Long-Term Survivors Developing Countries Oxazines Antitubercular Agents Disease Progression Follow-Up Studies Plasma Substance Abuse, Intravenous Incidence Pregnancy AIDS-Associated Nephropathy CD4-CD8 Ratio Saquinavir Longitudinal Studies CD8-Positive T-Lymphocytes HIV Seroprevalence Cameroon Haiti Kenya Antiviral Agents Thailand pol Gene Products, Human Immunodeficiency Virus Treatment Refusal Lesotho Homosexuality, Male Sarcoma, Kaposi Rwanda Hepatitis C

No FAQ available that match "antiretroviral therapy hiv 1"